UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Innovative Clinical Trials: The LUNG-MAP Study

Clinical pharmacology and therapeutics, 2015-05, Vol.97 (5), p.488-491

2015

Volltextzugriff (PDF)

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

Lung cancer (Amsterdam, Netherlands), 2014-02, Vol.83 (2), p.163-167

2014

Volltextzugriff (PDF)

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Cancer letters, 2007-09, Vol.254 (2), p.265-273

2007

Volltextzugriff (PDF)

Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors

Annals of oncology, 2012-04, Vol.23 (4), p.1023-1029

2012

Volltextzugriff (PDF)

Consensus for HER2 alterations testing in non-small-cell lung cancer

ESMO open, 2022-02, Vol.7 (1), p.100395-100395, Article 100395

2022

Volltextzugriff (PDF)

Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells

Molecular and Cellular Biology, 2001-03, Vol.21 (5), p.1565-1572

2001

Volltextzugriff (PDF)

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Cancer treatment and research communications, 2018, Vol.16, p.18-23

2018

Volltextzugriff (PDF)

Regulation of smooth muscle differentiation by the myocardin family of serum response factor co‐factors

Journal of thrombosis and haemostasis, 2005-09, Vol.3 (9), p.1976-1984

2005

Volltextzugriff (PDF)

Smooth Muscle α-Actin CArG Elements Coordinate Formation of a Smooth Muscle Cell–Selective, Serum Response Factor–Containing Activation Complex

Circulation research, 2000-02, Vol.86 (2), p.221-232

2000

Volltextzugriff (PDF)

Smooth Muscle Differentiation Marker Gene Expression Is Regulated by RhoA-mediated Actin Polymerization

The Journal of biological chemistry, 2001-01, Vol.276 (1), p.341-347

2001

Volltextzugriff (PDF)

Corrigendum to ‘Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer’: [ESMO Open Volume 7 Issue 1 (2022) 100395]

ESMO open, 2022-06, Vol.7 (3), p.100482-100482, Article 100482

2022

Volltextzugriff (PDF)

Enhancement of Radiation Cytotoxicity by UCN-01 in Non-small Cell Lung Carcinoma Cells

Radiation research, 2004-12, Vol.162 (6), p.623-634

2004

Volltextzugriff (PDF)

RB Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma

Clinical cancer research, 1999-09, Vol.5 (9), p.2596-2604

1999

Volltextzugriff (PDF)

Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia

Prostate cancer and prostatic diseases, 2004-12, Vol.7 (4), p.321-326

2004

Volltextzugriff (PDF)

Inhibition of Akt pathways in the treatment of prostate cancer

Prostate cancer and prostatic diseases, 2007-12, Vol.10 (4), p.331-339

2007

Volltextzugriff (PDF)

An Endogenous Inhibitor of Focal Adhesion Kinase Blocks Rac1/JNK but Not Ras/ERK-dependent Signaling in Vascular Smooth Muscle Cells

The Journal of biological chemistry, 2003-08, Vol.278 (32), p.29783-29791

2003

Volltextzugriff (PDF)

EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC

Clinical lung cancer, 2022-01, Vol.23 (1), p.60-71

2022

Volltextzugriff (PDF)

Pharmacodynamic separation of erlotinib and docetaxel (DOC) in advanced non-small cell lung cancer (NSCLC): Overcoming hypothesized antagonism

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7618-7618

2007

Volltextzugriff (PDF)

Apoptotic effects of the docetaxel→OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7143-7143

2004

Volltextzugriff (PDF)

Apoptotic effects of the docetaxel→OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7143-7143

2004

Volltextzugriff (PDF)

Evidence that NADPH‐dependent methemoglobin reductase and administered riboflavin protect tissues from oxidative injury

American journal of hematology, 1993-01, Vol.42 (1), p.13-18

1993

Volltextzugriff (PDF)

Ultrastructural demonstration of peroxidative activity and peroxidation in ischaemic and ischaemic-reperfused rabbit hearts

Cardiovascular research, 1993-03, Vol.27 (3), p.371-376

1993

Volltextzugriff (PDF)

Characterization of graf, the GTPase-activating protein for rho associated with focal adhesion kinase. Phosphorylation and possible regulation by mitogen-activated protein kinase

The Journal of biological chemistry, 1998-04, Vol.273 (14), p.8063-8070

1998

Volltextzugriff (PDF)

Impact of AKT inhibitor MK-2206 on erlotinib resistance in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7573-7573

2011

Volltextzugriff (PDF)

Overexpression of cyclin D1 is rare in human prostate carcinoma

The Prostate, 1999-01, Vol.38 (1), p.40-45

1999

Volltextzugriff (PDF)

1 – 25 von 1.754

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.510)
Mit Volltextzugriff
(1.465)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Innovative Clinical Trials: The LUNG-MAP Study

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors

Consensus for HER2 alterations testing in non-small-cell lung cancer

Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Regulation of smooth muscle differentiation by the myocardin family of serum response factor co‐factors

Smooth Muscle α-Actin CArG Elements Coordinate Formation of a Smooth Muscle Cell–Selective, Serum Response Factor–Containing Activation Complex

Smooth Muscle Differentiation Marker Gene Expression Is Regulated by RhoA-mediated Actin Polymerization

Corrigendum to ‘Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer’: [ESMO Open Volume 7 Issue 1 (2022) 100395]

Enhancement of Radiation Cytotoxicity by UCN-01 in Non-small Cell Lung Carcinoma Cells

RB Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma

Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia

Inhibition of Akt pathways in the treatment of prostate cancer

An Endogenous Inhibitor of Focal Adhesion Kinase Blocks Rac1/JNK but Not Ras/ERK-dependent Signaling in Vascular Smooth Muscle Cells

EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC

Pharmacodynamic separation of erlotinib and docetaxel (DOC) in advanced non-small cell lung cancer (NSCLC): Overcoming hypothesized antagonism

Apoptotic effects of the docetaxel→OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells

Apoptotic effects of the docetaxel→OSI-774 combination in non-small cell lung carcinoma (NSCLC) cells

Evidence that NADPH‐dependent methemoglobin reductase and administered riboflavin protect tissues from oxidative injury

Ultrastructural demonstration of peroxidative activity and peroxidation in ischaemic and ischaemic-reperfused rabbit hearts

Characterization of graf, the GTPase-activating protein for rho associated with focal adhesion kinase. Phosphorylation and possible regulation by mitogen-activated protein kinase

Impact of AKT inhibitor MK-2206 on erlotinib resistance in non-small cell lung cancer (NSCLC)

Overexpression of cyclin D1 is rare in human prostate carcinoma

Suchergebnisse filtern